I keep a close eye on cannabis and I would say that I partly agree with this statement and partly disagree. Cannabis stocks share prices are struggling. A few of the cowboys in the industry are getting found out. As such share prices are taking a bit of a hit.
However I agree that AVE should be getting the attention of the cannabis companies for two major reasons:
1. The improved absorption creates a more efficient product and should differentiate the cannabis companies product..
2. The potential ability to provide medicines with a more accurate dosage.
It really is a perfect time for technology like this to enter the cannabis market.
Having said that I don't think the rise in share price is to do with cannabis. Just seems that 1 mill dollars worth of trading is not your average joe trading and that it would more likely be something to do with injectables iMO
Ann: TPM Cannabinoid Development Program Update, page-98
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $1.604K | 534.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 41272233 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 39672334 | 32 |
View Market Depth
| Last trade - 15.59pm 18/11/2024 (20 minute delay) ? |
| AVE (ASX) Chart |